Subbu Nambi
Stock Analyst at Guggenheim
(4.17)
# 473
Out of 5,124 analysts
60
Total ratings
50%
Success rate
17.46%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Maintains: Buy | $45 → $50 | $44.72 | +11.81% | 5 | Jan 5, 2026 | |
| NTRA Natera | Maintains: Buy | $230 → $270 | $245.26 | +10.09% | 3 | Jan 5, 2026 | |
| ILMN Illumina | Maintains: Buy | $114 → $144 | $144.16 | -0.11% | 4 | Jan 5, 2026 | |
| GH Guardant Health | Maintains: Buy | $85 → $115 | $109.16 | +5.35% | 7 | Jan 5, 2026 | |
| DHR Danaher | Maintains: Buy | $250 → $275 | $235.78 | +16.63% | 3 | Jan 5, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $30 → $43 | $39.41 | +9.11% | 2 | Jan 5, 2026 | |
| BRKR Bruker | Maintains: Buy | $45 → $53 | $52.36 | +1.22% | 4 | Jan 5, 2026 | |
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $101.70 | - | 4 | Nov 21, 2025 | |
| GRAL GRAIL | Upgrades: Buy | $100 | $99.58 | +0.42% | 2 | Nov 12, 2025 | |
| PSNL Personalis | Maintains: Buy | $6 → $12 | $8.61 | +39.37% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $170 | $132.96 | +27.86% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $104.64 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $15.97 | +25.23% | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $68.69 | +38.30% | 4 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $27.67 | +30.10% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $7.38 | +35.50% | 3 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $36.23 | +38.01% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $9.88 | +1.21% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.45 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $4.80 | +25.00% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.89 | +217.46% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.64 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $171.92 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.03 | - | 1 | Dec 14, 2023 |
Veracyte
Jan 5, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $44.72
Upside: +11.81%
Natera
Jan 5, 2026
Maintains: Buy
Price Target: $230 → $270
Current: $245.26
Upside: +10.09%
Illumina
Jan 5, 2026
Maintains: Buy
Price Target: $114 → $144
Current: $144.16
Upside: -0.11%
Guardant Health
Jan 5, 2026
Maintains: Buy
Price Target: $85 → $115
Current: $109.16
Upside: +5.35%
Danaher
Jan 5, 2026
Maintains: Buy
Price Target: $250 → $275
Current: $235.78
Upside: +16.63%
Castle Biosciences
Jan 5, 2026
Maintains: Buy
Price Target: $30 → $43
Current: $39.41
Upside: +9.11%
Bruker
Jan 5, 2026
Maintains: Buy
Price Target: $45 → $53
Current: $52.36
Upside: +1.22%
Exact Sciences
Nov 21, 2025
Downgrades: Neutral
Price Target: n/a
Current: $101.70
Upside: -
GRAIL
Nov 12, 2025
Upgrades: Buy
Price Target: $100
Current: $99.58
Upside: +0.42%
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $6 → $12
Current: $8.61
Upside: +39.37%
Oct 29, 2025
Maintains: Buy
Price Target: $115 → $170
Current: $132.96
Upside: +27.86%
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $104.64
Upside: -
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $15.97
Upside: +25.23%
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $68.69
Upside: +38.30%
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $27.67
Upside: +30.10%
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.38
Upside: +35.50%
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $36.23
Upside: +38.01%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $9.88
Upside: +1.21%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $6.45
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $4.80
Upside: +25.00%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $1.89
Upside: +217.46%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $18.64
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $171.92
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.03
Upside: -